The LADR Zentrallabor Dr. Kramer & Kollegen, a laboratory in Geesthacht, Germany presented their evaluation of the APAS technology for both Infection Control (MRSA and VRE screening) and Urine screening applications at DGHM 2022 in Berlin.
The low prevalence (~1% in UK) of MRSA colonisation means much time is spent reading and reporting negative culture plates. Similarly, a large proportion of urine cultures yield no significant bacterial growth. As such, a large amount of scientist time is spent reporting negative samples.
Urine cultures (UC) constitute up to 30-40% of the workflow in clinical microbiology laboratories. Staffing considerations represent contemporary challenges, new tools are needed to address increasing demands and the evolving diversification of microbiology workflow.